Cargando…
The actual status of drug prices and adjustment factors for drug price calculation: an analysis of ultra-orphan drug development in Japan
BACKGROUND: Extremely high prices facilitate drug development for ultra-rare diseases (ultra-orphan drugs). However, various problems arise in terms of healthcare financing and fairness, and the status of ultra-orphan drug pricing remains ambiguous. In this study, we investigated ultra-orphan drug p...
Autores principales: | Kawakami, Akihiko, Masamune, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641848/ https://www.ncbi.nlm.nih.gov/pubmed/36348359 http://dx.doi.org/10.1186/s13023-022-02526-z |
Ejemplares similares
-
The impact of early phase price agreements on prices of orphan drugs
por: Nuijten, Mark, et al.
Publicado: (2021) -
Comparison of US and EU Prices for Orphan Drugs in the Perspective of the Considered US Orphan Drugs Act Modifications and Discussed Price-Regulation Mechanisms Adjustments in US and European Union
por: Żelewski, Paweł, et al.
Publicado: (2022) -
Establishing a reasonable price for an orphan drug
por: Berdud, Mikel, et al.
Publicado: (2020) -
Pricing of orphan drugs in oncology and rare diseases
por: Nuijten, Mark, et al.
Publicado: (2020) -
Orphan Drug Pricing: An Original Exponential Model Relating Price to the Number of Patients
por: Messori, Andrea
Publicado: (2016)